Thermo Fisher Scientific | الربح الإجمالي على المبيعات



Gross Profit On Sales تغيير تاريخ
Abbott USD 6.03B 93M 2024-12
Agilent USD 899M 18M 2025-01
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Bio Techne USD 196.58M 8.66M 2024-12
Bio-Rad Laboratories USD 355.1M 803K 2024-12
Boston Scientific USD 3.1B 194M 2024-12
Bruker USD 493.3M 74.5M 2024-12
Charles River Laboratories USD 319.68M 48.09M 2024-12
Danaher USD 3.89B 489M 2024-12
Dentsply International USD 455M 40M 2024-12
Edwards Lifesciences USD 1.09B 2.1M 2024-12
Exact Sciences USD 429.29M 83.29M 2024-12
General Electric USD 3.63B 702M 2024-12
Henry Schein USD 993M 0 2024-12
Hologic USD 580.5M 22.8M 2024-12
Illumina USD 728M 17M 2024-12
Intuitive Surgical USD 1.64B 268.3M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
Laboratory Of America USD 896.3M 8.1M 2024-12
Medtronic USD 5.52B 49M 2025-01
Mettler Toledo International USD 639.31M 66.85M 2024-12
Myriad Genetics USD 150.9M 1.1M 2024-12
Olympus JPY 167.98B 1.23B 2024-12
Patterson Companies USD 320.82M 7.27M 2025-01
Quest Diagnostics USD 858M 42M 2024-12
Repligen USD 77.49M 220K 2024-09
Revvity USD 412.29M 27.47M 2024-12
Stryker USD 4.2B 681M 2024-12
Thermo Fisher Scientific USD 4.82B 494M 2024-12
Veracyte USD 78.75M 256K 2024-12
Waters USD 524.2M 85.55M 2024-12
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Thermo Fisher Scientific الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.